Second potent anti-malarial candidate identified

UCT’s Drug Discovery and Development Centre, H3D, identifies a second potent anti-malarial candidate The University of Cape Town (UCT)’s Drug Discovery and Development Centre, H3D, has identified a new potent anti-malarial development candidate with potential for both treatment and prevention of malaria. The compound, referred to as UCT943, is the second preclinical candidate to come

Leave a Reply

Your email address will not be published. Required fields are marked *